Imperial College London


Faculty of MedicineDepartment of Medicine

Reader in Molecular Bacteriology & Infection



+44 (0)20 7594 2080v.pelicic Website




3.20Flowers buildingSouth Kensington Campus






BibTex format

author = {Cehovin, A and Kroll, JS and Pelicic, V},
doi = {10.1016/j.vaccine.2011.07.060},
journal = {Vaccine},
pages = {6858--6865},
title = {Testing the vaccine potential of PilV, PilX and ComP, minor subunits of Neisseria meningitidis type IV pili.},
url = {},
volume = {29},
year = {2011}

RIS format (EndNote, RefMan)

AB - Because meningitis and septicaemia caused by Neisseria meningitidis are major public health problems worldwide, the design of a broadly protective vaccine remains a priority. Type IV pili (Tfp) are surface-exposed filaments playing a key role in pathogenesis in a variety of bacterial species, including N. meningitidis, that have demonstrated vaccine potential. Unfortunately, in the meningococcus, the major pilus subunit PilE usually undergoes extensive antigenic variation and is therefore not suitable as a vaccine component. However, we have recently shown that N. meningitidis Tfp contain low abundance subunits PilX, PilV and ComP, collectively called minor pilins, that are highly conserved and modulate Tfp-linked functions key to pathogenesis. This prompted us to examine the vaccine potential of these proteins by assessing whether sera directed against them have bactericidal properties and/or are able to interfere with Tfp-linked functions. Here we show that minor pilin proteins are recognized by sera of patients convalescent from meningococcal disease and that antibodies directed against some of them can selectively interfere with Tfp-linked functions. This shows that, despite their apparent inability to elicit bactericidal antibodies, minor pilins might have vaccine potential.
AU - Cehovin,A
AU - Kroll,JS
AU - Pelicic,V
DO - 10.1016/j.vaccine.2011.07.060
EP - 6865
PY - 2011///
SP - 6858
TI - Testing the vaccine potential of PilV, PilX and ComP, minor subunits of Neisseria meningitidis type IV pili.
T2 - Vaccine
UR -
UR -
VL - 29
ER -